Clinical trial
ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions: a Pragmatic, Adaptive, Patient-oriented Randomized Controlled Trial
NCT04936607 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions: a Pragmatic, Adaptive, Patient-oriented Randomized Controlled Trial
- Lead sponsor
- Montreal Heart Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 28, 2021
- Completion date
- July 31, 2027
- Enrollment
- 1,158 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
contrast-induced acute kidney injury